The Effects of Valsartan on Cardiac Function and Pro-Oxidative Parameters in the Streptozotocin-Induced Diabetic Rat Heart
Open Access
- 1 September 2020
- journal article
- research article
- Published by Walter de Gruyter GmbH in Serbian Journal of Experimental and Clinical Research
- Vol. 21 (3) , 247-256
Abstract
Diabetes mellitus is a major risk factor for cardiovascular diseases, while cardiovascular diseases are a leading cause of morbidity and mortality worldwide. The renin–angiotensin– aldosterone system controls renal, cardiovascular, adrenal function and regulates fluid and electrolyte balance as well as blood pressure. Because of his role, inhibition of reninangiotensin-aldosteron system is another therapy approach that reduces the risk of diabetes and cardiovascular disease. In this study, our goal was to evaluate effect of valsartan,as inhibitor of angiotensin II receptor type 1, on cardiac tissue and function, with focus on cardiodynamic and oxidative stress. The present study was carried out on 20 adult male Wistar albino rats (8 week old and with body masses of 180-200 g). Rats were divided randomly into 2 groups (10 animals per group). Healthy animals treated with 1 μM of valsartan and streptozotocin-induced diabetic animals perfused with 1 μM of valsartan 4 weeks after the induction of diabetes. Our results demonstrated that acute application of valsartan has different effect on cardiodynamics in rat heart of diabetic and healthy animals but did not improve cardiac function in hyperglycemia-induced changes. A challenge for further investigations are studies with chronic or acute administration, alone or in combination with other angiotensin-converting-enzyme inhibitor in various models of diabetes.Keywords
This publication has 39 references indexed in Scilit:
- Angiotensin II, NADPH Oxidase, and Redox Signaling in the VasculatureAntioxidants & Redox Signaling, 2013
- l-Arginine prevents metabolic effects of high glucose in diabetic miceFEBS Letters, 2008
- Blockade of AT1 Receptor Reduces Apoptosis, Inflammation, and Oxidative Stress in Normotensive Rats with Intracerebral HemorrhageThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Rodent models of streptozotocin‐induced diabetic nephropathy (Methods in Renal Research)Nephrology, 2007
- Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trialJournal Of Hypertension, 2006
- Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiencyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin SystemDrugs, 2004
- Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic ratsJournal Of Hypertension, 2003
- A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in cultureJournal of Immunological Methods, 1980